GENEVA – Swiss drug maker Novartis yesterday said it has received samples of the swine flu A(H1N1) virus and is awaiting the World Health Organization (WHO)’s go-ahead to begin producing a vaccine.
“We have received the virus and our researchers have started looking into modifying it so we can begin producing a vaccine,” said a spokesman who added that it would take three to four weeks to get up and running.
“We are waiting for the green light from the WHO and the CDC (the US Centers for Disease Control and Prevention),” the spokesman said.
To read more, click here.
No comments:
Post a Comment